Inactive Instrument

Highlights Cardium Therapeutics Inc Nyse

Equities

US1419161062

End-of-day quote Nyse Other stock markets
- ^USD	-

2022	Gene Biotherapeutics, Inc. Auditor Raises 'Going Concern' Doubt	CI
2021	Gene Biotherapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2020	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Gene Biotherapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2020	03/09/21	CI
Gene Biotherapeutics Inc. Enters into an Agreement with Fujifilm Diosynth Biotechnologies to Manufacture the Generx Angiogenic Gene Therapy Product	26/04/21	CI
Gene Biotherapeutics Inc. Enters into an Agreement with the Olaregen Therapeutix Inc	13/09/18	CI
Gene Biotherapeutics Mulls Acquisitions	08/01/18	CI
Taxus Cardium Pharmaceuticals Group Inc. Receives Notice of Allowance from U.S. Patent and Trademark Office for New Patent Application	13/06/17	CI
Taxus Cardium Mulls Acquisitions	01/03/17	CI
Taxus Cardium Mulls Acquisitions	27/10/16	CI
Taxus Cardium Pharmaceuticals Group Inc. Enters into Binding Term Sheet with Dr. Reddy’S Laboratories Ltd	09/04/15	CI
TaxuCardium Pharmaceuticals Group Inc. Reports Consolidated Financial Results for the Third Quarter and Nine Months Ended September 30, 2014	20/11/14	CI
Cardium Announces Positive Interim Phase 3 Clinical Data Showing Significant Efficacy of Generx(R) Angiogenic Gene Therapy for Myocardial Ischemia Due to Coronary Artery Disease at the 2014 BIO International Convention	24/06/14	CI
Cardium Therapeutics to Announce Interim Results of Generx Angiogenic Gene Therapy Phase 3 Clinical Study at the 2014 Bio International Convention	12/06/14	CI
TaxuCardium Pharmaceuticals Group Inc. Announces Selection of Excellagen(R) For Use With Stem Cells in European Union-Funded Human Clinical Study	12/05/14	CI
Cardium Therapeutics Reports on Advancement of Generx and Excellagen Biologic Products	31/12/13	CI
Cardium Mulls Acquisitions	14/08/13	CI
Cardium Announces Excellagen Distribution Agreement with Kasiak for Germany and Switzerland	07/08/13	CI
Cardium Therapeutics Enters into an Agreement with Orbsen Therapeutics Ltd and the National University of Ireland	06/08/13	CI
Cardium Therapeutics Enters into Distribution Agreement with AvKARE Inc. Replaces Academy Medical, LLC	01/08/13	CI
American Podiatric Medical Association Grants Prestigious Seal of Approval to Cardium Therapeutics Inc.'s Innovative Excellagen	15/02/13	CI
Cardium Therapeutics Inc. Announces Sales and Distribution Agreement with Academy Medical, LLC	03/01/13	CI
Cardium Therapeutics Inc. Announces Launch Of New MedPodium Neo-Chill Nutra-App(R) at NACDS Marketplace 2012	19/06/12	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Cardium Therapeutics Inc Nyse

Equities

US1419161062

Highlights

Filters